检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]福建省药品检验所,福州350001 [2]福州市药品检验所,福州350007
出 处:《海峡药学》2014年第2期47-50,共4页Strait Pharmaceutical Journal
摘 要:目的 建立同时测定西洋参制剂中人参皂苷Rg1、Re、Rb1及抗疲劳类非法添加含量的液相色谱-质谱联用方法.方法采用Agilent ZORBAX SB-C18色谱柱(3.0mm×150mm,3.5μm),流动相A为含0.1%乙酸的20mmol·L-1乙酸铵溶液,流动相B为甲醇∶乙腈(3:2)的混合溶液,采用线性梯度洗脱;流速为200μL·min-1,柱温35℃.质谱条件采用电喷雾离子化(ESI)方式,正负离子模式,以多级反应监控(MRM)模式对西地那非、伐地那非、他达拉非、人参皂苷Rg1、Re和Rb1进行含量测定.结果 西地那非、伐地那非、他达拉非、人参皂苷Rg1、Re和Rb1分别在2.99~59.85,0.43~8.60,3.32~66.42,3.16~63.29,2.63~52.68,4.15~82.93μg·mL-1浓度范围内与峰面积呈良好线性关系.西洋参制剂中西地那非、伐地那非、他达拉非、人参皂苷Rg1、Re和Rb1的平均加样回收率均介于92.9%~103.3%之间.结论 本法简单、快速、灵敏、准确,可用于西洋参制剂中西地那非、伐地那非、他达拉非、人参皂苷Rg1、人参皂苷Re和Rb1含量测定,为该药的质量控制提供依据.OBJECTIVE To establish a LC-MS method for simultaneous determination of 6 compounds (Silde- nafil, Vardenafil, Tadalafil, Ginsenoside RgI , Re and Rb1 ) in American Ginseng Agent. METHODS The chromato- graphic separation was carried out at 35℃on a Aglient ZORBOX SB C18 column(3.0mm × 150mm,3.5μm) elated in a gradient program. Flow rate :200μL . min-1. The mobile phase A consisted of water containing 20mmol . L-1 ammonium acetate and 0.1% Acetic acid. The mobile phase B was methanol-acetonitrile (3:2). The mass spectra were obtained by Varian 310 triple quad mass spectrometer in MRM mode with eleetrospray ionization source in nega- tive and positive ion mode. RESULTS The linear ranges for Sildenafil, Vardenafil, Tadalafil. Ginsenoside Rg1,Re.and Rb1 were 2. 99 - 59.85,0. 43 - 8.60,3.32 - 66.42,3.16 -63.29,2. 63 - 52. 68,4. 15 - 82.93 μg . mL- 1, re- spectively. The average recoveries ranged between 92. 9% - 103.3%. CONCLUSION The established method is convenient,sensitive and accurate. It can be used for the determination of the contents of Sildenatil, Vardenafil, Tadalafil and Ginsenoside Rg1, Re and Rb1 in American Ginseng for quality control.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30